Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Blasetto

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|March 21, 2003
Efficacy of rosuvastatin 10 mg in patients with the metabolic syndromeChristie M Ballantyne, Evan A Stein, Rodolfo Paoletti, et al.
The American Journal of Cardiology|March 21, 2003
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groupsJames W Blasetto, Evan A Stein, W Virgil Brown, et al.
Lancet (London, England)|December 5, 2003
The stain warsGunnar O Olsson, James W Blasetto, Brian S Bryzinski, et al.
Current Medical Research and Opinion|July 28, 2007
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United StatesKathleen M Fox, Sanjay K Gandhi, Robert L Ohsfeldt, et al.
Clinical Therapeutics|December 26, 2007
Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record databaseKathleen M Fox, Sanjay K Gandhi, Robert L Ohsfeldt, et al.
The American Journal of Cardiology|January 27, 2005
Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndromePrakash C Deedwania, Donald B Hunninghake, Harold E Bays, et al.
Current Medical Research and Opinion|December 23, 2003
Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trialJames M McKenney, Peter H Jones, M Angeli Adamczyk, et al.
Current Medical Research and Opinion|October 7, 2004
Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapyJames Shepherd, Chris Packard, Thomas W Littlejohn, et al.
Clinical Therapeutics|November 9, 2004
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialPeter H Jones, Donald B Hunninghake, Keith C Ferdinand, et al.
The American Journal of Cardiology|July 16, 2003
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)Peter H Jones, Michael H Davidson, Evan A Stein, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|March 21, 2003
Efficacy of rosuvastatin 10 mg in patients with the metabolic syndromeChristie M Ballantyne, Evan A Stein, Rodolfo Paoletti, et al.
The American Journal of Cardiology|March 21, 2003
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groupsJames W Blasetto, Evan A Stein, W Virgil Brown, et al.
Lancet (London, England)|December 5, 2003
The stain warsGunnar O Olsson, James W Blasetto, Brian S Bryzinski, et al.
Current Medical Research and Opinion|July 28, 2007
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United StatesKathleen M Fox, Sanjay K Gandhi, Robert L Ohsfeldt, et al.
Clinical Therapeutics|December 26, 2007
Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record databaseKathleen M Fox, Sanjay K Gandhi, Robert L Ohsfeldt, et al.
The American Journal of Cardiology|January 27, 2005
Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndromePrakash C Deedwania, Donald B Hunninghake, Harold E Bays, et al.
Current Medical Research and Opinion|December 23, 2003
Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trialJames M McKenney, Peter H Jones, M Angeli Adamczyk, et al.
Current Medical Research and Opinion|October 7, 2004
Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapyJames Shepherd, Chris Packard, Thomas W Littlejohn, et al.
Clinical Therapeutics|November 9, 2004
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialPeter H Jones, Donald B Hunninghake, Keith C Ferdinand, et al.
The American Journal of Cardiology|July 16, 2003
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)Peter H Jones, Michael H Davidson, Evan A Stein, et al.
Pageof 2